HOME >> MEDICINE >> NEWS
Baylor researchers develop 'bubble' technique for potential treatment of Type I diabetes

(DALLAS, May 22, 2006)--Researchers at Baylor University Medical Center at Dallas and the Baylor Research Institute have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin. This approach is a major step in the potential treatment of Type I diabetes since patients with the disease do not produce enough insulin on their own. The research results were published in the May 2006 issue of the Proceedings of the National Academy of Sciences.

Insulin is a hormone that allows blood glucose (blood sugar) to enter the cells of the body to be used for energy. The technique, known as ultrasound-targeted microbubble destruction (UTMD), delivers these insulin genes to the organ via microscopic "bubbles." Once the bubbles reach their target, they are burst with ultrasound releasing the insulin genes into the pancreas.

Using UTMD, researchers delivered the bubbles containing human insulin genes into the pancreas of rats and later found that the rat's blood sugar had been subsequently lowered. Another gene that regulates insulin production, known as hexokinase I, was successfully delivered using UTMD as well, and resulted in increased blood insulin and decreased blood sugar in the rats.

"Not only was their blood sugar lowered, but there was no evidence of any damage to the pancreas," says Paul Grayburn, M.D., principal investigator of the study. "Other forms of gene therapy are usually invasive and unlike the UTMD technique, do not target the tissues and organs specifically."

Currently, patients with Type I (juvenile onset) diabetes must inject themselves with insulin daily to keep their blood sugar levels balanced in addition to following strict nutritional guidelines. Dr. Grayburn says that the UTMD technique is one of the most important steps in the development of a successful treatment of diabetes without the need for daily insulin injections.

"Now that we have successfully d
'"/>

Contact: Ashley Howland
ashlehow@baylorhealth.edu
214-820-7540
Baylor Health Care System
22-May-2006


Page: 1 2

Related medicine news :

1. Baylor Research Institute receives $6.2 million grant to establish Center for Lupus Research
2. Baylor Institute for Immunology research receives $3 million grant to create cancer vaccines
3. Stanford researchers find culprit in aging muscles that heal poorly
4. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
5. Penn researchers discover novel pathway for increasing good cholesterol
6. Theory of facial aging gets a facelift from UT Southwestern researchers
7. UIC researchers to develop new drugs to fight bioterrorism
8. UQ researchers discover some of the oldest forms of life
9. U of M researchers discover new method to combat HIV
10. U of M researchers assess effectiveness of computerized physician order entry system
11. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid

Post Your Comments:
(Date:5/18/2013)... In a May 14, 2013 article entitled “Angelina ... Cancer Gene,” Fox News reported the movie star had ... carried a gene that doctors estimated gave her an ... percent risk of ovarian cancer (go to: goo.gl/5JHBP). Ms. ... with a blog post entitled “A Patient’s Journey: Angelina ...
(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...
(Date:5/18/2013)... Gordon HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... sometimes binge drink, but new research shows that college women ... a weekly basis than are college men. Much ... that,s considered safe on a weekly basis is much lower ... women versus 14 for men. But, there,s good reason for ...
(Date:5/18/2013)... 2013 TheBeautyPlace.com answers important questions about ... is not a result of stress, nutrient deficiency or ... Magazine, 70% of men suffer from male patterned baldness. ... renowned for hair transplant surgery, but additionally carries a ... known as Bosley Professional Strength. Their product line is ...
(Date:5/18/2013)... During Better Hearing and Speech Month, parents ... protections they have, including the right to bring a ... treatment or hearing aid device, attorney Ronald E. Johnson ... Association has used the month of May to raise ... as cochlear implants, which can improve the quality of ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3
(Date:5/17/2013)... May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 31, 2013, before market on Tuesday, May 28, 2013.  The ... 2013, at 8:00 a.m. EDT (May 28, 2013 at 8:00 ... and provide an update on recent corporate developments. ...
(Date:5/16/2013)... SOUTH PLAINFIELD, N.J. , May 16, 2013 /PRNewswire/ ... a registration statement on Form S-1 with the U.S. ... initial public offering of its common stock. The number ... for the offering have not been determined. ... and Credit Suisse are acting as joint book-running managers ...
(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: